Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular potassium channels are a heterogeneous group of ion channels located in the plasma membrane of vascular smooth muscle and endothelial cells, where they serve as primary regulators of vascular resistance and blood flow (Jackson, 2018, Microcirculation). The major classes include voltage-gated (Kv), calcium-activated (KCa), ATP-sensitive (KATP), and inward-rectifier (Kir) potassium channels (Nelson & Quayle, 1995, Am J Physiol). By facilitating the efflux of potassium ions, these channels maintain the resting membrane potential; their opening causes hyperpolarization, which prevents the activation of voltage-gated calcium channels and leads to smooth muscle relaxation (Tykocki et al., 2017, Comprehensive Physiology). Impairment of K+ channel function is a hallmark of several vascular diseases, including hypertension and coronary artery disease. Therapeutic agents known as potassium channel openers, such as minoxidil and nicorandil, are used clinically to induce vasodilation in conditions like resistant hypertension and angina (PubChem, 2024). Despite their efficacy, systemic use can be limited by side effects like reflex tachycardia and fluid retention.
Activation of vascular K+ channels promotes potassium efflux, leading to membrane hyperpolarization of vascular smooth muscle cells. This hyperpolarization closes voltage-gated L-type calcium channels, reducing intracellular calcium concentration and causing vasodilation (Nelson & Quayle, 1995, Am J Physiol).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular potassium channel (K+ channel).